Using bright light therapy to help reduce depressive symptoms in adults with intellectual disabilities
Alleviation of Depressive Symptoms in People With Intellectual Disabilities
This study tests if bright light therapy can help reduce depression in adults with intellectual disabilities and improve their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 105 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Erasmus Medical Center Academic / other |
| Locations | 1 site (Rotterdam) |
| Trial ID | NCT06215235 on ClinicalTrials.gov |
What this trial studies
This study investigates the implementation of bright light therapy (BLT) for adults with intellectual disabilities who experience depressive symptoms. The research focuses on evaluating the process of implementing BLT at two different locations, starting with Amarant and then moving to Abrona. The study aims to gather insights on the effectiveness of BLT in reducing depressive symptoms and improving the quality of life for this population. Participants include both staff involved in the implementation and patients receiving the therapy.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with intellectual disabilities who are experiencing depressive symptoms and are receiving bright light therapy.
Not a fit: Patients who do not have intellectual disabilities or are not experiencing depressive symptoms may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the mental health and quality of life for adults with intellectual disabilities suffering from depression.
How similar studies have performed: Previous research has indicated that bright light therapy is a promising treatment for depressive symptoms in individuals with intellectual disabilities, suggesting potential success for this implementation study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Involved in the implementation of BLT (staff) OR * Involved in the prescription or application of BLT (staff/relatives) OR * receiving BLT for their depressive symptoms (patients with ID) * 18 years or older * informed consent Exclusion Criteria: * n/a
Where this trial is running
Rotterdam
- ErasmusMC — Rotterdam, Netherlands (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.